Showing 1 - 6 results of 6 for search 'D. Sallman', query time: 0.03s
Refine Results
-
1
Design and Implementation of Mobile Computing Simulator by Hayam A. Al-Yasiri, Nyan D. Sallman
Published 2014-12-01
Article -
2
2-Maximal Submodules and Related Concepts. by Haibat K. Mohammad ali, Akram S. Mohammed, Mohammad D. Sallman
Published 2018-06-01
Article -
3
P755: HYPERFERRITINEMIA IS A PREDICTIVE BIOMARKER OF POOR CLINICAL OUTCOMES IN CMML by L. E. Aguirre, S. Ball, A. Jain, N. Al Ali, D. Sallman, A. Kuykendall, K. Sweet, J. Lancet, E. Padron, R. Komrokji
Published 2022-06-01
Article -
4
PREDICTION OF POST-TRANSPLANT RELAPSE IN THE MYELODYSPLASTIC SYNDROMES VIA EVALUATION OF STEM CELLS by S. Chung, B. Kroger, Y. Huang, A. Son, P. Carlsgaard, L. Pop, R. Vittrup, F. Kalkan, A. Cherukuri, D. Sallman, R. Tamari, C. Gurnari, J. Maciejewski, Y. Madanat
Published 2024-01-01
Article -
5
P1073: MUTATIONAL LANDSCAPE AND CLINICAL OUTCOMES OF PATIENTS WITH MYELOID AND LYMPHOID NEOPLASMS WITH EOSINOPHILIA (MLN-EOS) AND ABNORMALITIES OF PDGFRA, PDGFRB, FGFR1, FLT3 AND J... by Y. Zhang, L. Nguyen, C. Lu, E. Wang, M. Lauw, S. Ball, N. Dong, L. Moscinski, O. Chan, S. Yun, D. Sallman, L. Sokol, B. Shah, J. Lancet, R. Komrokji, A. Kuykendall, E. Padron, L. Zhang
Published 2022-06-01
Article -
6
S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE... by N. G. Daver, P. Vyas, S. Kambhampati, M. M. Al Malki, R. Larson, A. Asch, G. Mannis, W. Chai-Ho, T. Tanaka, T. Bradley, D. Jeyakumar, E. Wang, G. Xing, M. Chao, G. Ramsingh, C. Renard, I. Lal, J. Zeidner, D. Sallman
Published 2022-06-01
Article